From NLR to TIN: What Can’t Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?
About:
This article is published in Annals of Surgical Oncology.The article was published on 2023-01-06 and is currently open access. It has received 0 citations till now. The article focuses on the topics: Medicine & Surgical oncology.read more
References
More filters
Journal ArticleDOI
IFN- γ –related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers,Jared Lunceford,Michael Nebozhyn,Erin Murphy,Andrey Loboda,David Ross Kaufman,Andrew Albright,Jonathan D. Cheng,S. Peter Kang,Veena Shankaran,Sarina Anne Piha-Paul,Jennifer H. Yearley,Tanguy Y. Seiwert,Antoni Ribas,Terrill K. McClanahan +14 more
TL;DR: The T cell–inflamed GEP contained IFN-&ggr;–responsive genes related to antigen presentation, chemokine expression, cytotoxic activity, and adaptive immune resistance, and these features were necessary, but not always sufficient, for clinical benefit.
Journal ArticleDOI
The tumor microenvironment and its role in promoting tumor growth.
TL;DR: The tumor microenvironment is created by the tumor and dominated by tumor-induced interactions, and various immune effector cells are recruited to the tumor site, their anti-tumor functions are downregulated, largely in response to tumor-derived signals.
Journal ArticleDOI
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
TL;DR: Tumor markers of esophageal cancer are an advancing area of research that could potentially lead to earlier diagnosis as well as playing a part in assessing tumor response to therapy.
Journal ArticleDOI
The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection.
Jing Jing Zhao,Ke Pan,Wei Wang,Ju gao Chen,Yan heng Wu,Lin Lv,Jian Jun Li,Yi Bing Chen,Dan Dan Wang,Qiu Zhong Pan,Xiao dong Li,Jian Chuan Xia +11 more
TL;DR: The presence of CD15+ TINs is an independent and unfavorable factor in the prognosis of gastric adenocarcinoma patients and Targeting CD15-TINs may be a potential intervenient therapy in the future.
Journal ArticleDOI
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma
TL;DR: The value of conventional cytotoxic treatment in MSI-H tumors is unclear and results on its efficacy range from detrimental to beneficial effects.